Related Experiment Video

Updated: Jan 17, 2026

Digital Home-Monitoring of Patients after Kidney Transplantation: The MACCS Platform
07:13

Digital Home-Monitoring of Patients after Kidney Transplantation: The MACCS Platform

Published on: April 12, 2021

4.9K

Medication Adherence Among Pilgrims with Chronic Diseases at Hajj 2024

Osama A Samarkandi1, Fahad Alamri2, Hala Aljishi2

  • 1Department of Basic Science, Prince Sultan College for Medical Emergencies, King Saud University, Riyadh, Saudi Arabia.

Medical Science Monitor : International Medical Journal of Experimental and Clinical Research
|September 23, 2025
PubMed

Insights

Pilgrims with chronic diseases showed poor medication adherence during Hajj, with supply issues and forgetfulness being key barriers. Targeted interventions are needed to improve health outcomes for this population.

Area of Science:

  • Public Health
  • Epidemiology
  • Pharmaceutical Sciences

Background:

  • Understanding medication use patterns in pilgrims is vital for safe and effective management during Hajj.
  • Chronic diseases and polypharmacy present significant health challenges for pilgrims undertaking the Hajj journey.

Purpose of the Study:

  • To evaluate medication adherence among pilgrims with chronic diseases during Hajj 2024.
  • To identify barriers to medication adherence in this specific patient population.

Main Methods:

  • A cross-sectional study was conducted using a pre-validated questionnaire at departure terminals.
  • Data collected included demographics, disease prevalence, medication adherence, and barriers to use.
  • Statistical analysis was performed using SPSS, with P<0.05 as the significance threshold.

Main Results:

  • A high prevalence of chronic diseases (40.1%) and polypharmacy (4.9%) was observed among pilgrims.
  • Medication adherence was inconsistent, with only 48.9% taking medications consistently.
  • Insufficient medication supply (25.7%) and forgetfulness (13.8%) were the primary barriers to adherence.

Conclusions:

  • Significant burden of chronic diseases and inconsistent medication adherence identified among Hajj pilgrims.
  • Age and education level were significantly associated with medication usage and adherence.
  • Targeted interventions are crucial for improving health outcomes during mass gatherings.

More Related Videos

Using Continuous Data Tracking Technology to Study Exercise Adherence in Pulmonary Rehabilitation09:42

Using Continuous Data Tracking Technology to Study Exercise Adherence in Pulmonary Rehabilitation

Published on: November 8, 2013

13.9K
E-Patient Counseling Trial E-PACO: Computer Based Education versus Nurse Counseling for Patients to Prepare for Colonoscopy06:28

E-Patient Counseling Trial E-PACO: Computer Based Education versus Nurse Counseling for Patients to Prepare for Colonoscopy

Published on: August 1, 2019

8.8K

Related Concept Videos

Drug Therapy01:28

Drug Therapy

The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
245
Drug Dosing: Geriatric Patients01:15

Drug Dosing: Geriatric Patients

Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
228
Bioavailability Study Design: Healthy Subjects Versus Patients01:15

Bioavailability Study Design: Healthy Subjects Versus Patients

Bioavailability studies are essential for evaluating a drug's therapeutic efficacy and understanding its absorption patterns under various physiological conditions. Conducting such studies on target patient populations provides more relevant data by simulating real-world disease states. However, practical challenges often necessitate the use of young, healthy adult volunteers as study subjects.Patients may exhibit altered drug absorption patterns due to the effects of the disease itself,...
144
Drug Dosing: Obese Patients01:21

Drug Dosing: Obese Patients

In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
225
Healthcare Associated Infections II: Preventive Measures01:22

Healthcare Associated Infections II: Preventive Measures

Essential infection prevention measures are based on the knowledge of the infection chain, the modes of transmission in healthcare settings, and the use of the best practices in all healthcare settings. Compulsory public reporting of healthcare-associated infection rates is needed to allow individuals and the community to make informed choices regarding selecting a healthcare facility.
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
3.6K
Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment01:08

Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment

Hepatic impairment, characterized by decreased liver function, does not uniformly mandate adjustments in drug dosage. Whether dosage modifications are necessary depends on various factors related to the drug's metabolism and elimination pathways. If a drug is primarily excreted via the kidneys and bypasses significant hepatic processing, if it undergoes minimal metabolic transformation in the liver, or if it is volatile and primarily expelled through the lungs, dose adjustments may not be...
257